Variables | Group A (n = 18) | Group L (n = 26) | P value | |
Age | 69.5 ± 12.8 | 64.1 ± 10.0 | 0.14 | |
Male sex (%) | 13 (72%) | 19 (73%) | 1.00 | |
Aneurymal diameter | ||||
(Antero-posterior) (mm) | 38.7 ± 19.1 | 28.3 ± 10.6 | 0.05 | |
Comorbidities | ||||
Hypertension | 13 (72%) | 18 (69%) | 1.00 | |
Ischemic heart disease | 1 (5%) | 8 (30%) | ||
Cerebrovascular disease | 4 (22%) | 7 (26%) | ||
Diabetes mellitus | 2 (11%) | 4 (15%) | ||
Respiratory failure | 6 (33%) | 6 (23%) | 0.50 | |
Chronic renal failure | 5 (27%) | 6 (23%) | 0.73 | |
Smoking (ex or current) | 10 (55%) | 19 (73%) | 0.33 | |
Anti-platelet or coagulant drug use | 9 (50%) | 16 (62%) | 0.54 | |
Operation | ||||
Operative time (min) | 276 ± 114 | 310 ± 87 | 0.28 | |
Intraoperative blood loss (ml) | 253 ± 225 | 193 ± 120 | 0.31 | |
Postoperative in-hospital duration (days) | 19.4 ± 11.1 | 22.7 ± 13.3 | 0.37 | |
Approach: | Median | 16 | 26 | |
Posterior | 2 | 0 | ||
Graft | Autovein | 12 | 24 | |
Prosthetic graft | 6 | 2 |